These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1710592

  • 1. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K, Goromaru T.
    Fundam Clin Pharmacol; 1990; 4(6):635-41. PubMed ID: 1710592
    [Abstract] [Full Text] [Related]

  • 2. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
    Hashimoto K, Maeda H, Goromaru T.
    Eur J Pharmacol; 1992 Sep 01; 228(2-3):171-4. PubMed ID: 1280228
    [Abstract] [Full Text] [Related]

  • 3. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 01; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 4. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 01; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 5. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF, Arora RC, Schreiber MA, Meltzer HY.
    Biochem Pharmacol; 1991 Jan 01; 41(1):79-84. PubMed ID: 1702633
    [Abstract] [Full Text] [Related]

  • 6. High-affinity [3H]6-nitroquipazine binding sites in rat brain.
    Hashimoto K, Goromaru T.
    Eur J Pharmacol; 1990 May 16; 180(2-3):273-81. PubMed ID: 1694774
    [Abstract] [Full Text] [Related]

  • 7. In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazine.
    Hashimoto K, Goromaru T.
    J Pharmacol Exp Ther; 1990 Oct 16; 255(1):146-53. PubMed ID: 2213550
    [Abstract] [Full Text] [Related]

  • 8. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K, Maeda H, Goromaru T.
    Brain Res; 1992 Sep 11; 590(1-2):341-4. PubMed ID: 1384935
    [Abstract] [Full Text] [Related]

  • 9. Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine.
    Classen K, Göthert M, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun 11; 326(3):198-202. PubMed ID: 6206407
    [Abstract] [Full Text] [Related]

  • 10. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Hashimoto K, Goromaru T.
    Neuropharmacology; 1991 Feb 11; 30(2):113-7. PubMed ID: 2030818
    [Abstract] [Full Text] [Related]

  • 11. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 11; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 12. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR, Peroutka SJ.
    Eur J Pharmacol; 1990 Feb 20; 177(1-2):95-8. PubMed ID: 1971219
    [Abstract] [Full Text] [Related]

  • 13. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 14. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
    Hewitt KE, Green AR.
    Neuropharmacology; 1994 Dec 29; 33(12):1589-95. PubMed ID: 7539115
    [Abstract] [Full Text] [Related]

  • 15. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI, Williams JL, Green AR.
    Br J Pharmacol; 1995 Aug 29; 115(7):1281-9. PubMed ID: 7582557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K, Goromaru T.
    Neuropharmacology; 1990 Jul 29; 29(7):633-9. PubMed ID: 1696701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.